Table of Contents The European Medicines Agency (EMA) needs many detailed studies to confirm that a vaccine is safe, provides adequate protection and is of suitable quality. As a public-health body safeguarding medicines in the European Union (EU), EMA will only approve a vaccine for COVID-19 after a thorough evalutation demonstrating the same high standards of quality, safety […]
Category Archives: Diagnostics
Technical briefing 9 This briefing provides an update on previous briefings up to 1 April 2021 Summary • There are 4 variants of concern and 7 variants under investigation (Table 1). VOC-20DEC-01 (B.1.1.7) remains predominant in the UK. Other variants of concern and variants under investigation remain a very low proportion of the available sequence […]
Technical briefing 8 This briefing provides an update on previous briefings up to 11 March 2021 Summary • There are 4 variants of concern and 6 variants under investigation (Table 1). Definitions for variants of concern, variants under investigation and signals in monitoring have been updated. VOC-20DEC-01 (B.1.1.7) remains predominant. Other variants of concern and […]
ad, Diagnostics
Veterinary diagnostics antibodies and antigens for animal health test kit, animal infectious diseases diagnostics and veterinary/Zoonotic diagnostic?laboratory in ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and POCT
Diagnostics, MPV, Uncategorized
Products & Information Collection of Monkeypox virus (MPV) – antibody pair for antigen rapid test, antigen for antibody serological test, both for ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT, neutralizing antibody for therapeutic drug discovery.
Information of Monkeypox virus (MPV) Prevalence and Perniciousness of MPV Monkeypox is a rare disease that is caused by infection with monkeypox virus. Monkeypox virus belongs to the Orthopoxvirus genus in the family Poxviridae. The Orthopoxvirus genus also includes variola virus (which causes smallpox), vaccinia virus (used in the smallpox vaccine), and cowpox virus. Monkeypox was first discovered in 1958 […]
Drug Discovery News The great escape: tumour cell plasticity in resistance to targeted therapy Review Article | 10 October 2019 The success of targeted therapies in cancer treatment has been impeded by various mechanisms of resistance. Besides the acquisition of resistance-conferring genetic mutations… Read More Targeting mRNA processing as an anticancer strategy Review Article | […]
1. GeneMedi information and products collection of SARS-COV-2 (2019nCOV) UK B.1.1.7 lineage and South Africa 501Y.V2 lineage and Brazilian P.1 lineage(B.1.1.28.1) Background Reading:Information and products collection of SARS-COV-2 (2019nCOV) UK B.1.1.7 lineageInformation and products collection of SARS-COV-2 (2019nCOV) South Africa 501Y.V2 lineageinformation and products collection of SARS-COV-2 (2019nCOV) Brazilian P.1 lineage (B.1.1.28.1) GeneMedi pseudotyped virus […]
PSV validated Data Poster Download Protocol Download BACKGROUND Challenge of COVID-19 vaccine discovery & development: to meet accumulated mutating of SARS-CoV-2 and a long-term viral genome transcrption COVID-19 (Coronavirus Disease 2019) is novel viral pneumonia caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, also called 2019nCoV). The world is in midst of the COVID-19 […]
COVID-19 vaccine development protocol: PSV Based Neutralization Assay 5. Vaccines development for COVID-19/SARS-CoV-2 Coronavirus Disease 2019 (COVID-19) is a novel viral pneumonia caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). First discovered in Wuhan, a city in Hubei province of China, COVID-19 has already broken out throughout the world and posed a great threat […]
Variant of Concern 2021/03 Technical briefing 7 This briefing provides an update on previous briefings up to 13 February 2021 Summary • There are 4 variants of concern and 5 variants under investigation (Table 1) • A slightly increased risk of hospitalisation has been now been detected for VOC 202012/01 (B.1.1.7), supporting previous findings on […]
